Application note: Characterization of ImmTAC® bispecific molecules with Alto™ digital SPR
Immunocore’s ImmTAC technology is a novel class of biologics that target cancer cells through T-cell redirecting immunotherapy. Bispecific molecules, or bispecifics, are a growing subset of biothera...
